tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BCRX Stock Latest News

BioCryst announces new data at ACAAI on ORLADEYO
The FlyBioCryst announces new data at ACAAI on ORLADEYO
2d ago
BCRX
BioCryst reports inducement grants under Nasdaq listing rule
PremiumThe Fly
BioCryst reports inducement grants under Nasdaq listing rule
3d ago
BCRX
BioCryst price target lowered to $25 from $27 at Citizens JMP
PremiumThe Fly
BioCryst price target lowered to $25 from $27 at Citizens JMP
3d ago
BCRX
BioCryst Pharmaceuticals Shines in Q3 Earnings Call
PremiumCompany Announcements
BioCryst Pharmaceuticals Shines in Q3 Earnings Call
3d ago
BCRX
BioCryst’s Strong Growth and Strategic Moves Reinforce Buy Rating
PremiumRatings
BioCryst’s Strong Growth and Strategic Moves Reinforce Buy Rating
4d ago
BCRX
BioCryst price target lowered to $9 from $11 at Barclays
PremiumThe FlyBioCryst price target lowered to $9 from $11 at Barclays
4d ago
BCRX
BioCryst Pharmaceuticals Reports Strong Q3 2025 Results
Premium
Company Announcements
BioCryst Pharmaceuticals Reports Strong Q3 2025 Results
4d ago
BCRX
BioCryst’s Orladeyo: Strong Growth and Strategic Moves Reinforce Buy Rating
Premium
Ratings
BioCryst’s Orladeyo: Strong Growth and Strategic Moves Reinforce Buy Rating
4d ago
BCRX
BioCryst Reports Q3 2025 Financial Growth and Strategy
PremiumCompany Announcements
BioCryst Reports Q3 2025 Financial Growth and Strategy
5d ago
8K
BCRX
BioCryst raises FY25 net ORLADEYO revenue view to $590M-$600M
PremiumThe Fly
BioCryst raises FY25 net ORLADEYO revenue view to $590M-$600M
5d ago
BCRX
BioCryst reports Q3 adjusted EPS 16c, consensus 8c
PremiumThe Fly
BioCryst reports Q3 adjusted EPS 16c, consensus 8c
5d ago
BCRX
BioCryst Pharmaceuticals (BCRX) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
BioCryst Pharmaceuticals (BCRX) Q3 Earnings Cheat Sheet
7d ago
BCRX
BioCryst’s Strategic Acquisition of Astria Therapeutics and Promising HAE Treatment Drive Buy Rating
PremiumRatingsBioCryst’s Strategic Acquisition of Astria Therapeutics and Promising HAE Treatment Drive Buy Rating
23d ago
BCRX
BioCryst price target raised to $26 from $24 at Cantor Fitzgerald
Premium
The Fly
BioCryst price target raised to $26 from $24 at Cantor Fitzgerald
24d ago
ATXS
BCRX
BioCryst’s Strategic Acquisition of Astria Therapeutics: Enhancing HAE Portfolio with Navenibart
Premium
Ratings
BioCryst’s Strategic Acquisition of Astria Therapeutics: Enhancing HAE Portfolio with Navenibart
24d ago
BCRX
BioCryst price target raised to $27 from $17 at Citizens JMP
PremiumThe Fly
BioCryst price target raised to $27 from $17 at Citizens JMP
24d ago
ATXS
BCRX
BioCryst reinstated with a Buy at TD Cowen
PremiumThe Fly
BioCryst reinstated with a Buy at TD Cowen
24d ago
ATXS
BCRX
BioCryst weakness presents ‘compelling’ buying opportunity, says RBC
PremiumThe Fly
BioCryst weakness presents ‘compelling’ buying opportunity, says RBC
24d ago
ATXS
BCRX
BioCryst’s Strategic Acquisition of ATXS: A Catalyst for Long-Term Growth and Profitability
PremiumRatings
BioCryst’s Strategic Acquisition of ATXS: A Catalyst for Long-Term Growth and Profitability
24d ago
BCRX
BioCryst’s Strategic Acquisition of Astria Therapeutics Boosts Market Position and Financial Outlook
PremiumRatingsBioCryst’s Strategic Acquisition of Astria Therapeutics Boosts Market Position and Financial Outlook
24d ago
BCRX
BioCryst price target raised to $15 from $14 at Jefferies
Premium
The Fly
BioCryst price target raised to $15 from $14 at Jefferies
24d ago
ATXS
BCRX
Astria Therapeutics downgraded to Hold from Buy at Jefferies
Premium
The Fly
Astria Therapeutics downgraded to Hold from Buy at Jefferies
24d ago
ATXS
BCRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >